PMID- 11390353 OWN - NLM STAT- MEDLINE DCOM- 20010705 LR - 20220330 IS - 0890-9369 (Print) IS - 0890-9369 (Linking) VI - 15 IP - 11 DP - 2001 Jun 1 TI - Malignant glioma: genetics and biology of a grave matter. PG - 1311-33 FAU - Maher, E A AU - Maher EA AD - Center for Neuro-Oncology, Boston, Massachusetts 02115, USA. FAU - Furnari, F B AU - Furnari FB FAU - Bachoo, R M AU - Bachoo RM FAU - Rowitch, D H AU - Rowitch DH FAU - Louis, D N AU - Louis DN FAU - Cavenee, W K AU - Cavenee WK FAU - DePinho, R A AU - DePinho RA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PT - Review PL - United States TA - Genes Dev JT - Genes & development JID - 8711660 RN - 0 (Growth Substances) RN - EC 2.7.11.22 (Cyclin-Dependent Kinases) SB - IM MH - Animals MH - Cell Differentiation MH - Cyclin-Dependent Kinases/genetics/metabolism MH - Disease Models, Animal MH - Genes, Retinoblastoma MH - Genes, Tumor Suppressor MH - Genes, p53 MH - Glioma/blood supply/*genetics/*pathology MH - Growth Substances/genetics/metabolism MH - Humans MH - Mice MH - Neovascularization, Pathologic RF - 170 EDAT- 2001/06/08 10:00 MHDA- 2001/07/06 10:01 CRDT- 2001/06/08 10:00 PHST- 2001/06/08 10:00 [pubmed] PHST- 2001/07/06 10:01 [medline] PHST- 2001/06/08 10:00 [entrez] AID - 10.1101/gad.891601 [doi] PST - ppublish SO - Genes Dev. 2001 Jun 1;15(11):1311-33. doi: 10.1101/gad.891601.